BrightHeart’s AI-based software for prenatal congenital heart defect (CHD) screening has demonstrated promise in two new studies. The French company’s AI software received 510(k) clearance ...
BrightHeart’s innovative AI technology addresses a critical unmet clinical need, targeting the significant challenge of screening for congenital heart defects (CHDs), the most common type of ...
BrightHeart’s innovative AI technology addresses a critical unmet clinical need, targeting the significant challenge of screening for congenital heart defects (CHDs), the most common type of birth ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback